Skip to main content
. 2018 Sep 11;10:101–111. doi: 10.2147/CPAA.S171044

Table 3.

Adverse events and drug-related adverse events

[System Organ Class]
Preferred term
Adverse events
Drug-related adverse events
1 mg
N=29
4 mg
N=28
12 mg
N=26
1 mg
N=29
4 mg
N=28
12 mg
N=26
n (%) n (%) n (%) n (%) n (%) n (%)
Patients with any events 9 31.0 8 28.6 10 38.5 0 1 3.6 1 3.8
[Blood and lymphatic system disorders] 3 10.3 1 3.6 0 0 0 0
Anemia 2 6.9 1 3.6 0 0 0 0
Nephrogenic anemia 1 3.4 0 0 0 0 0
[Cardiac disorders] 0 0 1 3.8 0 0 0
Supraventricular tachycardia 0 0 1 3.8 0 0 0
[Eye disorders] 0 3 10.7 1 3.8 0 0 0
Conjunctival hemorrhage 0 0 1 3.8 0 0 0
Dry eye 0 1 3.6 0 0 0 0
Optic nerve cupping 0 1 3.6 0 0 0 0
Punctate keratitis 0 1 3.6 0 0 0 0
[Gastrointestinal disorders] 0 2 7.1 2 7.7 0 1 3.6 1 3.8
Vomiting 0 1 3.6 1 3.8 0 1 3.6 0
Diarrhea 0 1 3.6 0 0 0 0
Nausea 0 0 1 3.8 0 0 1 3.8
[General disorders and administration site condition] 0 0 1 3.8 0 0 0
Chest pain 0 0 1 3.8 0 0 0
[Infections and infestations] 1 3.4 1 3.6 1 3.8 0 0 0
Nasopharyngitis 1 3.4 0 1 3.8 0 0 0
Pharyngitis 0 1 3.6 0 0 0 0
[Injury, poisoning, and procedural complications] 1 3.4 1 3.6 1 3.8 0 0 0
Shunt occlusion 1 3.4 0 0 0 0 0
Vascular procedure complication 0 1 3.6 0 0 0 0
Procedural nausea 0 0 1 3.8 0 0 0
[Investigations] 0 0 1 3.8 0 0 0
C-reactive protein increased 0 0 1 3.8 0 0 0
[Musculoskeletal and connective tissue disorders] 1 3.4 0 0 0 0 0
Neck pain 1 3.4 0 0 0 0 0
[Psychiatric disorders] 0 1 3.6 0 0 0 0
Insomnia 0 1 3.6 0 0 0 0
[Renal and urinary disorders] 0 1 3.6 0 0 0 0
Hematuria 0 1 3.6 0 0 0 0
[Reproductive system and breast disorders] 0 0 1 3.8 0 0 0
Breast mass 0 0 1 3.8 0 0 0
[Respiratory, thoracic, and mediastinal disorders] 0 1 3.6 1 3.8 0 0 0
Rhinorrhea 0 0 1 3.8 0 0 0
Upper respiratory tract inflammation 0 1 3.6 0 0 0 0
[Skin and subcutaneous tissue disorders] 5 17.2 2 7.1 0 0 0 0
Dermatitis contact 4 13.8 1 3.6 0 0 0 0
Dermal cyst 0 1 3.6 0 0 0 0
Eczema 1 3.4 0 0 0 0 0